- Home
- CRVO vs PHUN Comparison
CRVO vs PHUN Comparison
Compare CRVO & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- PHUN
- Stock Information
- Founded
- CRVO 2001
- PHUN 2009
- Country
- CRVO United States
- PHUN United States
- Employees
- CRVO N/A
- PHUN N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- PHUN EDP Services
- Sector
- CRVO Health Care
- PHUN Technology
- Exchange
- CRVO Nasdaq
- PHUN Nasdaq
- Market Cap
- CRVO 67.4M
- PHUN 55.9M
- IPO Year
- CRVO N/A
- PHUN N/A
- Fundamental
- Price
- CRVO $8.50
- PHUN $2.92
- Analyst Decision
- CRVO Strong Buy
- PHUN Buy
- Analyst Count
- CRVO 6
- PHUN 2
- Target Price
- CRVO $19.17
- PHUN $7.75
- AVG Volume (30 Days)
- CRVO 92.4K
- PHUN 250.9K
- Earning Date
- CRVO 11-11-2025
- PHUN 11-06-2025
- Dividend Yield
- CRVO N/A
- PHUN N/A
- EPS Growth
- CRVO N/A
- PHUN N/A
- EPS
- CRVO N/A
- PHUN N/A
- Revenue
- CRVO $7,776,968.00
- PHUN $2,400,000.00
- Revenue This Year
- CRVO N/A
- PHUN N/A
- Revenue Next Year
- CRVO N/A
- PHUN $72.40
- P/E Ratio
- CRVO N/A
- PHUN N/A
- Revenue Growth
- CRVO N/A
- PHUN N/A
- 52 Week Low
- CRVO $1.80
- PHUN $2.22
- 52 Week High
- CRVO $16.94
- PHUN $14.60
- Technical
- Relative Strength Index (RSI)
- CRVO 51.94
- PHUN 55.90
- Support Level
- CRVO $7.90
- PHUN $2.70
- Resistance Level
- CRVO $8.93
- PHUN $3.13
- Average True Range (ATR)
- CRVO 0.42
- PHUN 0.15
- MACD
- CRVO 0.06
- PHUN 0.02
- Stochastic Oscillator
- CRVO 84.30
- PHUN 55.32
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.